Answers are grounded in this paper and cite their sources.
Introduction We present a lab-on-foil (LOF) microfluidic platform for point-of-care (POC) genetic testing, combining roll-to-roll UV nanoimprint lithography (R2R UV-NIL) with on-chip loop-mediated isothermal amplification (LAMP) and sequence-specific detection of single nucleotide polymorphisms (SNPs). Methods The integrated system comprises an R2R UV-NIL-fabricated microfluidic chip with a portable reader enabling controlled isothermal incubation, automated reagent handling, and chemiluminescence-based signal detection. Analytical validation was performed using 67 genomic DNA samples with known LCT –13910C>T genotypes, with 167 measurement runs conducted across four reader instruments. Genotype classification was based on allele-specific signal ratios and predefined quality-control criteria. Results Of these 167 runs, 49 (29.3%) met the acceptance criteria and were included in the diagnostic performance analysis. Using the final decision thresholds, the assay achieved 100.0% sensitivity and 80.6% specificity for identification of the clinically relevant C/C genotype, with a positive predictive value of 65.0% and a negative predictive value of 100%. Genotype discrimination was achieved within approximately 50 min. Discussion The results confirm the compatibility of scalable R2R-fabricated microfluidic chips with integrated nucleic acid amplification and allele-specific detection workflows. While the analytical assay principle proved functional, overall system performance was primarily limited by fluidic handling, temperature uniformity, and reagent delivery during prototype integration. Overall, the presented platform demonstrates the potential of scalable lab-on-foil technologies for decentralized genetic diagnostics and future multiplexed POC testing applications.
No takes yet. Share an insight, caveat, or question.
Angermann-Krammer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: